Disparity in use of orthotopic liver transplantation among blacks and whites

Liver Transplantation

Volumn 10, Issue 7, 2004, Pages 834-841

  Reid, Andrea E ^a   Resnick, Maria ^a   Chang, YuChiao ^a   Buerstatte, Nathan ^a   Weissman, Joel S ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFRICAN AMERICAN; AGE; ARTICLE; CLINICAL FEATURE; DEMOGRAPHY; DISEASE SEVERITY; ETHNIC DIFFERENCE; FEMALE; HEALTH CARE ACCESS; HEALTH CARE UTILIZATION; HEPATITIS; HUMAN; HUMAN TISSUE; LIFE EXPECTANCY; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FAILURE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; ORTHOTOPIC TRANSPLANTATION; OUTCOMES RESEARCH; PATIENT REFERRAL; PREDICTION; PRIORITY JOURNAL; STANDARDIZATION;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HISPANIC AMERICANS; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; TISSUE AND ORGAN PROCUREMENT; UNITED STATES; WAITING LISTS;

EID: 3242780991     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1002/lt.20174     Document Type: Article

References (38)

1. Ayanian J, Cleary P, Weissman J, Epstein A. The effect of patients' preferences on racial differences in access to renal transplantation. N Engl J Med 1999;341:1661-1669.
2. Alexander G, Sehgal A. Barriers to cadaveric renal transplantation among blacks, women, and the poor. JAMA 1998;280: 1148-1152.
3. Schulman KA, Berlin JA, Harless W, Kerner JF, Sistrunk S, Gersh BJ, et al. The effect of race and sex on physicians' recommendations for cardiac catheterization. N Engl J Med 1999;340: 618-626.
4. Carlisle D, Leake B, Shapiro M. Racial and ethnic differences in the use of cardiovascular procedures: associations with type of health insurance. Am J Public Health 1997;87:263-267.
5. Bach P, Cramer L, Warren J, Begg C. Racial differences in the treatment of early-stage lung cancer. N Engl J Med 1999;341: 1198-1205.
6. Schneider E, Zaslavsky A, Epstein A. Racial disparities in the quality of care for enrollees in Medicare managed care. JAMA 2002;287(10):1288-1294.
7. Eckhoff DE, McGuire BM, Young CJ, Sellers MT, Frenette LR, Hudson SL, et al. Race: a critical factor in organ donation, patient referral and selection, and orthotopic liver transplantation? Liver Transpl Surg 1998;4:499-505.
8. Wei Y, Detre K, Everhart J. The NIDDK liver transplantation database. Liver Transpl Surg 1997;3:10-22.
9. Gonwa T, Morris C, Mai M, Husberg B, Goldstein R, Klintmalm G. Race and liver transplantation. Arch Surg 1991;126: 1141-1143.
10. Klassen A, Klassen D, Brookmeyer R, Frank R, Marconi K. Factors influencing waiting time and successful receipt of cadaveric liver transplant in the United States: 1990 to 1992. Med Care 1998;36:281-294.
11. Freeman R, Edwards E. Liver transplantation waiting time does not correlate with waiting list mortality: implications for liver allocation policy. Liver Transpl 2000;6:543-552.
12. U.S. Census Bureau. Population Estimates for States by Age, Race, Sex, and Hispanic Origin: July 1, 1997. Available at: http://eire.census.gov/popest/archives/state/sasrh/sasrh97.txt. Accessed March 1, 2001.
13. Transplant and Waiting List Patient Information: Data from the United Network for Organ Sharing and the Organ Procurement and Transplantation Network as of 1999.
14. Rothman K, Greenland S. Modern Epidemiology. 2 ed. Vol. 1 Philadelphia, Pa: Lippincott-Raven Publishers; 1998.
15. Compressed Mortality File [database on CD-ROM]. Hyattsville, Md: National Center for Health Statistics, Centers for Disease Control and Prevention; 1989-1998.
16. Hurwitz E, Holman R, Strine T, Chorba T. Chronic liver disease mortality in the United States, 1979 through 1989. Am J Public Health 1995;85:1256-1260.
17. Alter MJ, Kruszon-Moran D, Nainan OV, McQuillan GM, Gao F, Moyer LA., et al. Prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999;341: 556-562.
18. McHutchinson JG, Poynard T, Pianko S, Gordon SC, Reid AE, Dienstag J, et al. The impact of interferon plus ribavirin on response to therapy in black patients with chronic hepatitis C. The International Hepatitis Interventional Therapy Group. Gastroenterology 2000;119:1317-1323.
19. Reddy KR, Hoofnagle JH, Tong MJ, Lee WM, Pockros P, Heathcote EJ., et al. Racial differences in responses to therapy with interferon in chronic hepatitis C. Hepatology 1999;30: 787-793.
20. Kim W, Gross JJ, Poterucha J, Locke Gr, Dickson E. Outcome of hospital care of liver disease associated with hepatitis C in the United States. Hepatology 2001;33:201-206.
21. Grant B, Zobeck T, Pickering R. Liver cirrhosis mortality in the United States, 1973-87. Bethesda, MD: US Department of Health and Human Services, Alcohol, Drug Abuse, and Mental Health Administration, National Institute on Alcohol Abuse and Alcoholism; 1990.
22. Frieden TR. Ozick L. McCord C. Nainan OV. Workman S. Comer G., et al. Chronic liver disease in Harlem: the role of alcohol and viral hepatitis. Hepatology 1999;29:883-888.
23. McQuillan G, Coleman P, Kruszon-Moran D, Moyer L, Lambert S, Margolis H. Prevalence of hepatitis B virus infection in the United States: The National Health and Nutrition Examination Surveys, 1976 through 1994. Am J Public Health 1999; 89:14-18.
24. El-Serag H, Mason A. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999;340:745-750.
25. Sehgal A. Outcomes of renal replacement therapy among blacks and women. Am J Kidney Dis 2000;35(Suppl 1):S148-S152.
26. Fiscella K, Franks P, Gold M, Clancy C. Inequality in qualty: addressing socioeconomic, racial, and ethnic disparities in health care. JAMA 2000;283(19):2579-2584.
27. Lantz P, House J, Lepkowski J, Williams D, Mero R, Chen J. Socioeconomic factors, health behaviors, and mortality: results from a nationally representative study of US adults. JAMA 1998; 279:1703-1708.
28. Sorlie P, Backlund E, Keller J. US mortality by economic, demographic, and social characteristics: the national longitudinal mortality study. Am J Public Health 1995;85:949-956.
29. Nair S, Eustace J, Thuluvath P. Effect of race on outcome of orthotopic liver transplantation: a cohort study. Lancet 2002; 359:287-293.
30. Wiesner R. Edwards E. Freeman R. Harper A. Kim R. Kamath P., et al. United Network for Organ Sharing Liver Disease Severity Score Committee. Model for End-Stage Liver Disease (MELD) and Allocation of Donor Livers. Gastroenterology 2003;124:91-96.
31. United Network for Organ Sharing and the University Renal Research and Education Association. 2002 Annual data report, chapter VII: liver and intestine transplantation. Available at: http://www.optn.org/data/annualReport.asp?url=/Data/AR2002/ ar02_chapter_seven.htm. Accessed August 13, 2003.
32. Freeman RJ, Wiesner R, Edwards E, Harper A, Merion R, Wolfe R. Results of the First Year of the New Liver Allocation Plan. Liver Transpl 2004;10:7-15.
33. Ozminkowski R, White A, Hassol A, Murphy M. Minimizing racial disparity regarding receipt of a cadaver kidney transplant. Am J Kidney Dis 1997;36:749-759.
34. Gaylin DS, Held PJ, Port FK, Hunsicker LG, Wolfe RA, Kahan BD, et al. The impact of comorbid and sociodemographic factors on access to renal transplantation. JAMA 1993;269:603-608.
35. Soucie J, Neylan J, McClellan W. Race and sex differences in identification of candidates for renal transplantation. Am J Kidney Disease 1992;19:414-419.
36. Kasiske BL, Neylan JF 3rd, Riggio RR, Danovitch GM, Kahana L, Alexander SR, et al. The effect of race on access and outcome in transplantation. N Engl J Med 1991;324:302-307.
37. Held P, Pauly M, Bovbjerg R, Newmann J, Salvatierra O. Access to kidney transplantation: has the United States eliminated income and racial differences? Arch Intern Med 1988; 148:2594-2600.
38. Holley J, McCauley C, Doherty B, Stackiewicz L, Johnson J. Patients' view in the choice of renal transplant. Kidney Int 1996; 49:494-498.